Neurobiology of Aging
Volume 30, Issue 11 , Pages 1711-1723 , November 2009

A meta-analysis of hippocampal atrophy rates in Alzheimer's disease

  • Josephine Barnes

      Affiliations

    • Dementia Research Centre, University College London, Institute of Neurology, Queen Square, London, UK
    • Corresponding Author InformationCorresponding author at: Dementia Research Centre, Box 16, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK. Tel.: +44 845 155 5000x723804; fax: +44 207 676 2066.
    • ,
  • Jonathan W. Bartlett

      Affiliations

    • London School of Hygiene and Tropical Medicine, London, UK
    • ,
  • Laura A. van de Pol

      Affiliations

    • Department of Neurology, Alzheimer Center, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
    • ,
  • Clement T. Loy

      Affiliations

    • Prince of Wales Medical Research Institute, Sydney, Australia
    • ,
  • Rachael I. Scahill

      Affiliations

    • Dementia Research Centre, University College London, Institute of Neurology, Queen Square, London, UK
    • ,
  • Chris Frost

      Affiliations

    • Dementia Research Centre, University College London, Institute of Neurology, Queen Square, London, UK
    • London School of Hygiene and Tropical Medicine, London, UK
    • ,
  • Paul Thompson

      Affiliations

    • Laboratory of Neuro Imaging, Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Nick C. Fox

      Affiliations

    • Dementia Research Centre, University College London, Institute of Neurology, Queen Square, London, UK

Received 9 July 2007 ,Revised 4 January 2008 ,Accepted 18 January 2008.

References 

  1. Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, et al. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol. Aging. 2007;28:20–28
  2. Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, et al. Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral. Neurobiol. Aging. 2007;28:1657–1663
  3. Barnes J, Scahill RI, Boyes RG, Frost C, Lewis EB, Rossor CL, et al. Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage. 2004;23:574–581
  4. Barnes J, Scahill RI, Schott JM, Frost C, Rossor MN, Fox NC. Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement. Geriatr. Cogn. Disord. 2005;19:338–344
  5. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 1993;33:403–408
  6. Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, Jagust WJ, et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol. Aging. 2003;24:537–544
  7. Dawbarn D, Allen SJ. Neurobiology of Alzheimer's disease. Oxford University Press; 2001;Edition 2
  8. Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust WJ, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology. 2004;62:422–427
  9. Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, et al. Atrophy rates of entorhinal cortex in AD and normal aging. Neurol. 2003;60:481–486
  10. Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, et al. Effects of A beta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology. 2005;64:1563–1572
  11. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain. 1996;119:2001–2007
  12. Hampel H, Burger K, Pruessner JC, Zinkowski R, DeBernardis J, Kerkman D, et al. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch. Neurol. 2005;62:770–773
  13. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. Am. J. Psychiatry. 2005;162:676–682
  14. Haller JW, Banerjee A, Christensen GE, Gado M, Joshi SC, Miller MI, et al. Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomical atlas. Radiology. 1997;202:504–510
  15. Hsu YY, Schuff N, Du AT, Mark K, Zhu X, Hardin D, et al. Comparison of Automated and Manual MRI Volumetry of Hippocampus in Normal Aging and Dementia. J. Magn. Reson. Imaging. 2002;16:305–310
  16. Jack CR, Petersen RC, Xu Y, O’Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484–489
  17. Jack CR, Petersen RC, Xu Y, O’Brien PC, Smith GE, Ivnik RJ, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51:993–999
  18. Jack CR, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology. 2003;60:253–260
  19. Jack CRJ, Shiung MM, Gunter JL, O’Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62:591–600
  20. Kaye JA, Moore MM, Dame A, Quinn J, Camicioli R, Howieson D, et al. Asynchronous regional brain volume losses in presymptomatic to moderate AD. J. Alzheimers Dis. 2005;8:51–56
  21. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurol. 1997;48:1297–1304
  22. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am. J. Psychiatry. 2003;160:2003–2011
  23. Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H. Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biol. Psychiatry. 2000;47:557–561
  24. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurol. 2000;55:134–136
  25. Mori E, Lee K, Yasuda M, Hashimoto M, Kazui H, Hirono N, et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann. Neurol. 2002;51:209–214
  26. Morrell CH. Likelihood ratio testing of variance components in the linear mixed-effects model using restricted maximum likelihood. Biometrics. 1998;54:1560–1568
  27. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65:565–571
  28. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 2006;5:828–834
  29. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 2003;60:989–994
  30. Scheltens P, Fox NC, Barkhof F, DeCarli CD. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1:13–21
  31. Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC. Measuring atrophy in Alzheimer disease—a serial MRI study over 6 and 12 months. Neurology. 2005;65:119–124
  32. Sharp SJ. Meta-analysis regression. Stata Technical Bulletin, vol. 42. 1998;pp. 16–22
  33. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 2003;61:487–492
  34. Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 1997;278:1363–1371
  35. Thompson PM, Hayashi KM, de Zubicaray GI, Janke AL, Rose SE, Semple J, et al. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage. 2004;22:1754–1766
  36. Wang L, Swank JS, Glick IE, Gado MH, Miller MI, Morris JC, et al. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage. 2003;20:667–682

PII: S0197-4580(08)00026-2

doi: 10.1016/j.neurobiolaging.2008.01.010

Neurobiology of Aging
Volume 30, Issue 11 , Pages 1711-1723 , November 2009

Article Tools

* Image Usage & Resolution